Johnson & Johnson said on Monday it had filed a lawsuit against Samsung Bioepis for breaching its contract agreement with the ...

Recent developments in the health sector include Pfizer appointing Patrizia Cavazzoni as Chief Medical Officer and Amgen ...

Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre ...

Glucagon-like peptite-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With ...

Amgen (NASDAQ: AMGN) is investing $200 million in its new technology and innovation center in Hyderabad, India, to enhance AI ...

Amgen (AMGN) plans to invest about $200M this year in its new technology center in southern India, with further investments planned, Reuters’ ...

Amgen, a leading American biopharmaceutical company, is set to invest $200 million in a new Technology and Innovation Centre.

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

In the final days of 2024, three pharmaceutical giants sued the federal government. In their joint lawsuit, Amgen, Eli Lilly ...

Manufacturers of medicines, including Pfizer and Eli Lilly, have spent a combined $450,000 lobbying against price caps on ...